Medplus Subsidiary Receives Drug License Suspension Order for Karnataka Store
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services Limited, has received an order suspending the Drug License for one of its stores located in Bangalore, Karnataka. The suspension action was issued by the Drugs Control Administration Bangalore Circle-5 and concerns a facility situated at Kacharakanahalli.The store's Drug License has been suspended for two days. The action was initiated following a review under Rule 65 of the Drugs and Cosmetics Act, 1940 and its corresponding Rules, 1945.
According to the details provided regarding the disciplinary measure, the order was received on June 9, 2026. The violation pertains to contraventions alleged against the store's license compliance.
A summary of the licensing matter is detailed below:
| Authority Name | Action Taken | Date of Order Receipt | Alleged Violation | Financial Impact |
|---|---|---|---|---|
| Assistant Director, Drugs Control Administration Bangalore Circle-5 | Suspension of Drug License for two days of store in Kacharakanahalli, Karnataka. | 09.06.2026 | Under Rule 65 of Drugs and Cosmetics Act, 1940 and Rules, 1945 | Potential Revenue Loss of Rs 1.48 lacs |
The suspension impacts the operational activities of the subsidiary, resulting in a potential revenue loss estimated at Rs 1.48 lacs.
MEDPLUS Stock Price Movement
Medplus Health Services Limited shares closed today after slipping 0.43% to settle at ₹859.45. The stock traded amidst a range spanning from ₹845.4 to ₹868.95, with total volume reaching 106,917 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.